Cargando…

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer

BACKGROUND: Colorectal cancer patients have an increased risk of developing venous thromboembolism (VTE), resulting in increased morbidity and mortality. Because the exact mechanism is yet unknown, risk prediction is still challenging; therefore, new biomarkers are needed. MicroRNAs (miRNAs) are sma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anijs, Rayna J. S., Laghmani, El Houari, Ünlü, Betül, Kiełbasa, Szymon M., Mei, Hailiang, Cannegieter, Suzanne C., Klok, Frederikus A., Kuppen, Peter J. K., Versteeg, Henri H., Buijs, Jeroen T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248312/ https://www.ncbi.nlm.nih.gov/pubmed/35794963 http://dx.doi.org/10.1002/rth2.12749

Ejemplares similares

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
por: Cannegieter, Suzanne C., et al.
Publicado: (2020)

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
por: Nab, Linda, et al.
Publicado: (2022)

Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Klok, Frederikus A., et al.
Publicado: (2019)

Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer Study
por: Crobach, Monique J. T., et al.
Publicado: (2023)

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
por: van der Wall, Sake J., et al.
Publicado: (2018)

Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism
por: Kooiman, Judith, et al.
Publicado: (2015)

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
por: Hendriks, Stephan V., et al.
Publicado: (2020)

The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
por: Kooiman, Judith, et al.
Publicado: (2015)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Cancer‐associated thrombosis: The search for the holy grail continues
por: Ünlü, Betül, et al.
Publicado: (2018)

Sex‐specific aspects of venous thromboembolism: What is new and what is next?
por: Scheres, Luuk J. J., et al.
Publicado: (2022)

Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older
por: Wang, Huijie, et al.
Publicado: (2023)

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism
por: Scheres, Luuk J.J., et al.
Publicado: (2020)

Risk of cancer in patients with thyroid disease and venous thromboembolism
por: Christensen, Diana H, et al.
Publicado: (2018)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In Vitro
por: Kapteijn, Maaike Y., et al.
Publicado: (2023)

Association of recurrent venous thromboembolism and circulating microRNAs
por: Wang, Xiao, et al.
Publicado: (2019)

Estimating Venous Thromboembolism Risk in Foot and Ankle Surgical Patients: A Base-Population Case-Control Study
por: Zambelli, Roberto, et al.
Publicado: (2019)

Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma
por: Kaptein, Fleur H. J., et al.
Publicado: (2022)

Endogenous sex hormones and risk of venous thromboembolism in young women
por: Scheres, Luuk J. J., et al.
Publicado: (2019)

MiRNAs and Their Role in Venous Thromboembolic Complications
por: Gareev, Ilgiz, et al.
Publicado: (2023)

Clinical risk assessment model to predict venous thromboembolism risk after immobilization for lower-limb trauma
por: Nemeth, Banne, et al.
Publicado: (2020)

Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma
por: Kaptein, Fleur H.J., et al.
Publicado: (2022)

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study
por: Orsi, Fernanda A., et al.
Publicado: (2021)

Prophylaxis and treatment of COVID-19 related venous thromboembolism
por: Kaptein, F.H.J., et al.
Publicado: (2021)

Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization
por: Douillet, D., et al.
Publicado: (2019)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort
por: Paulsen, Benedikte, et al.
Publicado: (2021)

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
por: Gade, Inger Lise, et al.
Publicado: (2018)

Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study
por: Rokx, Casper, et al.
Publicado: (2020)

Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
por: Kroone, Chantal, et al.
Publicado: (2023)

Venous thromboembolism /
por: Hirsh, Jack, 1935-
Publicado: (1981)

Nutrition and venous thrombosis: An exercise in thinking about survivor bias
por: Lijfering, Willem M., et al.
Publicado: (2018)

A systematic review of biomarkers among hospitalized patients with COVID‐19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Variables Scientific and Standardization Committee of the ISTH
por: Woller, Scott C., et al.
Publicado: (2022)

Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study
por: Klok, Frederikus A., et al.
Publicado: (2018)

Pulmonary thromboembolic events in COVID‐19—A systematic literature review
por: Overton, Paul M., et al.
Publicado: (2022)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
por: Orsi, Fernanda A., et al.
Publicado: (2019)

Thalassemia and Venous Thromboembolism
por: Succar, Julien, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2a1g97uv0vehpcuoicvm18h1bc